Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
On July 31, 2026, the Health Resources and Services Administration (HRSA) announced (Notice) a revised 340B Rebate Model Pilot Program (Pilot) that would allow participating drug manufacturers to provide 340B discounts through retrospective rebates.
On July 28, 2026, the Centers for Medicare & Medicaid Services (CMS) announced the Calendar Year (CY) 2027 Part D national average monthly bid amount is $296.05, the Part D base beneficiary premium is $41.33, and the de minimis amount is $2.
The Academy of Managed Care Pharmacy (AMCP) thanks the Office of Management and Budget (OMB) for the opportunity to provide comments in response to the proposed rule titled Regulation for Federal Financial Assistance.
On July 16, 2026, the Centers for Medicare and Medicaid Services released revised draft guidance on how manufacturers must effectuate the Maximum Fair Price (MFP) under the Medicare Price Negotiation Program for Initial Price Applicability Year (IPAY) 2028.
AMCP's Q3 2026 Precision Medicine Bulletin is now available, featuring a recap of key precision medicine developments from 2026, a review of recent clinical guidelines, highlights from new publications in the field, and updates on AMCP's submission to the National Comprehensive Cancer Network (NCCN).
The Academy of Managed Care Pharmacy (AMCP) convened stakeholders across managed care, patient advocacy, life sciences, and research for its Partnership Forum, Insights to Impact: Advancing the Use of Patient Experience Data in Payer Decision-Making, held in Alexandria, Va., in June 2026. The forum focused on how patient experience data (PED) can be more consistently evaluated and applied within payer decision-making frameworks.
